Prosecution Insights
Last updated: April 19, 2026

Cls Therapeutics Limited

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18563348 IMMUNOMODULATION OF TUMOR MICROENVIRONMENT PRIEST, JESSICA MARIE 1642 Non-Final OA Nov 21, 2023
17626616 TREATMENT OF DISEASES ASSOCIATED WITH PROTEIN MISFOLDING BY NERVOUS SYSTEM EXPRESSION OF AN ENZYME WHICH HAS A DEOXYRIBONUCLEASE (DNase) ACTIVITY WEN, SHARON X 1641 Final Rejection Jan 12, 2022

Managing Cls Therapeutics Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month